Table 1.
Patient ID | Sex | Age | Primary site | Grade | Treatment | CellSearch CTCs | Parsortix CTCs | WBC | Fresh tissue single cells | FFPE single cells | FFPE bulk samples |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 74 | Small intestine | 2 | na | 4 | na | 4 | na | na | na |
2 | F | 45 | Small intestine | 3 | PEN-221 | 15 | 5 | na | na | 2 | Pituitary metastasis |
3 | F | 69 | Small intestine | 2 | na | 7 | 8 | na | 8 | na | Small bowel |
4 | M | 65 | Small intestine | 1 | SSA | 18 | na | na | na | na | Small bowel |
5 | M | 47 | Pancreas | 2 | na | 12 | na | 4 | na | na | na |
6 | M | 64 | GOJ | 3 | na | 11 | na | na | na | 1 | na |
7 | F | 33 | Renal | 2 | PEN-221 | 21 | 11 | 10 | na | 2 | na |
All tissue samples are FFPE unless specifically indicated otherwise.
F, female; FFPE, formalin-fixed paraffin-embedded; GOJ, gastro-esophageal junction; M, male; na, not applicable; SSA, somatostatin analogs; PEN-221, novel antibody-drug conjugate.